ES2136247T3
Oral dosage forms of azithromycin avoiding drugfood interaction
Abstract
THE INVENTION PROVIDES THE USE OF AZITHROMYCIN IN THE MANUFACTURE OF AN ORAL ADMINISTRATION THAT RAPIDLY WITHIN HIGH BIOUTILITY FOR THE TREATMENT OF A MICROBIAL INFECTION IN A MAMMER THAT HAS EAT OR EATS IN THE PERIOD THAT BEGINS 1 HOURS BEFORE THE TERM 2 HOURS AFTER ADMINISTRATION.
Term
Term ended
Projected expiry passed 20 April 2015, 11.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
57 members in 31 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 19940235069 | United States of America | – | |
| 23506994 | United States of America | A | |
| 23506994 | United States of America | A | |
| 95302628 | – | – | – |
| US19940235069 | – | – | – |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| FI952060A0 | Finland | A0 | |
| NO951630D0 | Norway | D0 | |
| AP9500728A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| HU9501206D0 | Hungary | D0 | |
| IL113437A0 | Israel | A0 | |
| IL113437D0 | Israel | D0 | |
| UY23935A1 | Uruguay | A1 | |
| CA2148071A1 | Canada | A1 | |
| FI952060A | Finland | A | |
| FI952060A7 | Finland | A7 | |
| FI952060L | Finland | L | |
| NO951630L | Norway | L | |
| EP0679400A1 | European Patent Office (EPO) | A1 | |
| AU1771195A | Australia | A | |
| JPH07300420A | Japan | A | |
| KR950028764A | Republic of Korea | A | |
| LV10918A | Latvia | A | |
| MA23533A1 | Morocco | A1 | |
| CN1114879A | China | A | |
| TNSN95046A1 | Tunisia | A1 | |
| LV10918B | Latvia | B | |
| ZA953439B | South Africa | B | |
| AP566A | African Regional Intellectual Property Organization (ARIPO) | A | |
| OA10151A | African Intellectual Property Organization (OAPI) | A | |
| RU95106639A | Russian Federation | A | |
| US5605889A | United States of America | A | |
| HUT75244A | Hungary | A | |
| UY24614A1 | Uruguay | A1 | |
| CO4560547A1 | Colombia | A1 | |
| YU27195A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| RU2128998C1 | Russian Federation | C1 | |
| IL126588A0 | Israel | A0 | |
| IL126588D0 | Israel | D0 | |
| EP0679400B1 | European Patent Office (EPO) | B1 | |
| AU709328B2 | Australia | B2 | |
| AT183395T | Austria | T | |
| ATE183395T1 | Austria | T1 | |
| DE69511451D1 | Germany | D1 | |
| SI0679400T1 | Slovenia | T1 | |
| ES2136247T3This record | Spain | T3 | |
| DK0679400T3 | Denmark | T3 | |
| DE69511451T2 | Germany | T2 | |
| GR3031290T3 | Greece | T3 | |
| CA2148071C | Canada | C | |
| IL126588A | Israel | A | |
| UA34464C2 | Ukraine | C2 | |
| IL113437A | Israel | A | |
| DZ1877A1 | Algeria | A1 | |
| CN1088362C | China | C | |
| TW499311B | Taiwan Province of China | B | |
| KR100354310B1 | Republic of Korea | B1 | |
| NO314386B1 | Norway | B1 | |
| JP2005015466A | Japan | A | |
| USRE39149E | United States of America | E | |
| YU49483B | Yugoslavia, later Serbia and Montenegro (until 2006) | B | |
| NZ548384A | New Zealand | A | |
| JP2008231120A | Japan | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Definitive protectionFG2A | FG2A |
Numbers
- Publication
- 2136247
- Publication, DOCDB
- 2136247
- Publication, EPODOC
- ES2136247T
- Application
- 95302628
- Application, DOCDB
- 95302628
- Application, EPODOC
- ES19950302628T
Titles2
- Spanish
- FORMAS DE DOSIFICACION ORAL DE AZITROMICINA QUE NO MUESTRAN UN EFECTO ALIMENTO ADVERSO.
- English
- ORAL DOSAGE FORMS OF AZITHROMYCIN THAT DOES NOT SHOW AN ADVERSE FOOD EFFECT.
Classification
- CPC, 8
- A61K31/70
- A61K31/7052
- A61K9/0095
- A61P31/00
- A61P31/04
- A61K9/20
- A61K9/14
- A61K9/08
- IPC, 13
- C07H17 00
- A61K9 00
- A61K9 10
- A61K9 14
- A61K9 20
- A61K31 70
- A61K31 7042
- A61K31 7048
- A61K31 7052
- A61K47 02
- A61P31 00
- A61P31 04
- C07H17 08